CFL1 and Alzheimer disease: Rods have been described during the progression of AD and other neurodegenerative diseases where they contribute to cytoskeletal abnormalities and synaptic dysfunction through the disruption of normal actin dynamics, the blocking of neuronal transport, and the sequestration of cofilin [21–24].